Neuberger Berman Group
LMAT icon

Neuberger Berman Group’s LeMaitre Vascular LMAT Stock Holding History

Neuberger Berman Group’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$610K Sell
6,355
-762
-11% -$78.1K ﹤0.01% 1716
2026
Q1 		$777K Buy
7,117
+316
+5% +$30.1K ﹤0.01% 1499
2025
Q4 		$552K Sell
6,801
-324
-5% -$27.9K ﹤0.01% 1596
2025
Q3 		$624K Sell
7,125
-685
-9% -$61.2K ﹤0.01% 1530
2025
Q2 		$649K Sell
7,810
-175
-2% -$14.6K ﹤0.01% 1502
2025
Q1 		$670K Buy
7,985
+283
+4% +$26.3K ﹤0.01% 1459
2024
Q4 		$710K Buy
7,702
+33
+0.4% +$3.17K ﹤0.01% 1416
2024
Q3 		$712K Sell
7,669
-265
-3% -$23K ﹤0.01% 1406
2024
Q2 		$653K Buy
7,934
+37
+0.5% +$2.72K ﹤0.01% 1407
2024
Q1 		$524K Sell
7,897
-8,565
-52% -$529K ﹤0.01% 1483
2023
Q4 		$934K Buy
16,462
+9,050
+122% +$474K ﹤0.01% 1510
2023
Q3 		$404K Buy
7,412
+208
+3% +$12.3K ﹤0.01% 1510
2023
Q2 		$485K Sell
7,204
-2,316
-24% -$141K ﹤0.01% 1456
2023
Q1 		$490K Buy
9,520
+282
+3% +$13.7K ﹤0.01% 1467
2022
Q4 		$425K Sell
9,238
-89
-1% -$4.17K ﹤0.01% 1496
2022
Q3 		$473K Sell
9,327
-294
-3% -$14.7K ﹤0.01% 1490
2022
Q2 		$438K Buy
9,621
+2,396
+33% +$107K ﹤0.01% 1528
2022
Q1 		$336K Sell
7,225
-47
-0.6% -$2.1K ﹤0.01% 1657
2021
Q4 		$364K Sell
7,272
-166
-2% -$8.58K ﹤0.01% 1648
2021
Q3 		$394K Buy
7,438
+97
+1% +$5.46K ﹤0.01% 1520
2021
Q2 		$448K Sell
7,341
-107
-1% -$5.68K ﹤0.01% 1502
2021
Q1 		$363K Sell
7,448
-1,124
-13% -$52.7K ﹤0.01% 1561
2020
Q4 		$347K Sell
8,572
-336
-4% -$12K ﹤0.01% 1480
2020
Q3 		$290K Buy
+8,908
New +$267K ﹤0.01% 1462

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Neuberger Berman Group's LMAT Position: Q2 2026 in Review

Neuberger Berman Group reduced its LeMaitre Vascular (LMAT) stake by 11% in Q2 2026, selling an estimated $78.1K and leaving 6,355 shares worth $610K. The position accounts for ﹤0.01% of the portfolio, ranked #1716.

Neuberger Berman Group first reported a position in LMAT in Q3 2020 and has held it in 24 quarters since. The position peaked at $934K in Q4 2023. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Neuberger Berman Group held 6,355 shares of LeMaitre Vascular worth $610K as of Q2 2026.
  • Neuberger Berman Group sold 762 LeMaitre Vascular shares in Q2 2026, an estimated $78.1K.
  • LeMaitre Vascular made up ﹤0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #1716 holding.
  • Neuberger Berman Group first reported a position in LeMaitre Vascular in Q3 2020 and has held it in 24 quarters since.
  • Neuberger Berman Group's LeMaitre Vascular position peaked at $934K in Q4 2023.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.